We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$91.2B
AUM Growth
+$11.2B
Cap. Flow
+$2B
Cap. Flow %
2.19%
Top 10 Hldgs %
23.22%
Holding
3,971
New
387
Increased
1,763
Reduced
1,480
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 14.58%
2 Healthcare 8.49%
3 Financials 8.3%
4 Consumer Discretionary 6.61%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
3601
Rockwell Medical
RMTI
$27.9M
$52K ﹤0.01%
471
+74
+19% +$8.29K
AMC icon
3602
AMC Entertainment Holdings
AMC
$2.14B
$50K ﹤0.01%
+2,346
New +$76.7K
DWSN icon
3603
Dawson Geophysical
DWSN
$138M
$50K ﹤0.01%
23,550
GDX icon
3604
CALL
VanEck Gold Miners ETF
GDX
$27.5B
$49K ﹤0.01%
+32,200
New +$1.2M
HMY icon
3605
Harmony Gold Mining
HMY
$12.2B
$49K ﹤0.01%
+10,522
New +$51.9K
ENB icon
3606
CALL
Enbridge
ENB
$113B
$47K ﹤0.01%
+44,300
New +$1.35M
APD icon
3607
CALL
Air Products & Chemicals
APD
$68.9B
$46K ﹤0.01%
28,600
-2,600
-8% -$732K
FGNA.WS
3608
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$46K ﹤0.01%
+31,532
New +$31.4K
HWM icon
3609
CALL
Howmet Aerospace
HWM
$112B
$45K ﹤0.01%
+11,900
New +$265K
FGB
3610
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
$44K ﹤0.01%
+14,155
New +$41.1K
ASXC
3611
DELISTED
Asensus Surgical, Inc.
ASXC
$44K ﹤0.01%
70,355
RVLP
3612
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$44K ﹤0.01%
+10,725
New +$61.8K
IWF icon
3613
CALL
iShares Russell 1000 Growth ETF
IWF
$127B
$43K ﹤0.01%
40,800
ACER
3614
DELISTED
Acer Therapeutics Inc
ACER
$42K ﹤0.01%
16,200
CCO icon
3615
Clear Channel Outdoor Holdings
CCO
$1.23B
$41K ﹤0.01%
25,000
NAT icon
3616
Nordic American Tanker
NAT
$1.31B
$41K ﹤0.01%
+13,976
New +$45.6K
OEC icon
3617
CALL
Orion
OEC
$377M
$41K ﹤0.01%
+14,500
New +$221K
TMDI
3618
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$41K ﹤0.01%
24,205
+8,529
+54% +$8.47K
ATHX
3619
DELISTED
Athersys, Inc. Common Stock
ATHX
$41K ﹤0.01%
939
+399
+74% +$18.1K
DAN icon
3620
CALL
Dana Inc
DAN
$3.27B
$40K ﹤0.01%
18,100
MPC icon
3621
CALL
Marathon Petroleum
MPC
$94.5B
$40K ﹤0.01%
81,100
-37,200
-31% -$1.34M
ENG
3622
CALL
DELISTED
ENGlobal Corp
ENG
$40K ﹤0.01%
+5,938
New +$68K
CPRX
3623
DELISTED
Catalyst Pharmaceutical
CPRX
$39K ﹤0.01%
11,726
SPG icon
3624
CALL
Simon Property Group
SPG
$71B
$39K ﹤0.01%
24,200
+1,700
+8% +$130K
TSM icon
3625
CALL
TSMC
TSM
$2.19T
$39K ﹤0.01%
11,200
-9,100
-45% -$863K

Similar funds

Raymond James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James & Associates held 3,971 positions worth $91.2B, up 14% from $80B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2020 filing shows 387 new, 1,763 increased, 1,480 reduced and 217 closed positions. Its largest new stake was Bentley Systems: 330,402 shares worth $13.4M. The largest sale was United Parcel Service, an estimated $69.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2020 buy was Bentley Systems: 330,402 shares worth $13.4M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $158M increase.
  • Raymond James & Associates's biggest Q4 2020 reduction was United Parcel Service, cutting an estimated $69.6M.
  • Raymond James & Associates fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q4 2020, selling an estimated $54.2M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $91.2B portfolio in Q4 2020.
  • Raymond James & Associates opened 387 new positions and closed 217 in Q4 2020.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $91.2B.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.